0 – Cambridge Enterprise

Drugs

First of new generation of cancer drugs granted European approval

19 December 2014 • 4 min read

Aqdot closes £2.55m funding round

17 December 2014 • 2 min read

Sapientia: one step closer to fast, definitive diagnosis of rare genetic diseases

08 December 2014 • 5 min read

Cambridge academics win GSK’s Discovery Fast Track Challenge

01 December 2014 • 4 min read

blue drugs and needle

FDA approves MS drug developed by University of Cambridge researchers

17 November 2014 • 4 min read

Cambridge Epigenetix raises $5.5M

31 October 2014 • 2 min read

Lynparza recommended for approval in ovarian cancer

24 October 2014 • 4 min read

New Cambridge Enterprise office opens on Biomedical Campus

29 September 2014 • 2 min read

Shaun Formal

Breathing Buildings CEO named Royal Academy Fellow

17 September 2014 • 3 min read

Scientists reset human stem cells to earliest developmental state

12 September 2014 • 5 min read

Another record year for University of Cambridge spinout investments

10 September 2014 • 4 min read

Puzzle magazine based on University research supports childhood learning

28 August 2014 • 2 min read